Key Takeaways ICON is advancing with AI tools like iSubmit and SmartDraft to streamline clinical trial operations. ICLR's alliance with Mural Health supports patient-first clinical trial tech and payment solutions. Macroeconomic pressure weighed on ICLR's Q1 revenues and gross margin.ICON plc (ICLR) is well-poised to grow in the upcoming quarters, driven by its strategic additions. Leveraging AI and technology advancements, the company is optimizing clinical delivery and has seen strong improvements acros ...